Project Grant R35GM154813
- The National Institute of General Medical Sciences (NIGMS) awarded The Johns Hopkins University a $458,950 Project Grant effective May 1, 2026, through January 31, 2031, under the Biomedical Research and Research Training program (CFDA 93.859). The project, "Deciphering Signaling Network Dynamics, Structure, and Function," delivers fundamental research aimed at understanding how cells detect and respond to environmental cues through complex signaling networks. The research will produce...
- This $448,150 Project Grant awarded by the National Science Foundation (NSF) Biological Sciences program (CFDA 47.074) aims to develop a DNA-based toolbox for the rapid and precise modulation of cell membrane protein-protein interactions (PPIs). The goal is to establish a modular approach using antibodies and aptamers to enable targeted DNA barcoding of cell membrane proteins, particularly receptor tyrosine kinases. This will allow for the controlled stabilization of specific PPI pairs on living...
- This National Science Foundation (NSF) Biological Sciences program project grant, awarded to Oregon Health & Science University (OHSU), aims to uncover the underlying biophysical mechanisms of directed cell migration. The $1,049,497 grant, with a period of performance from January 2024 to December 2027, will examine how actin cytoskeletal networks and adhesion receptors interact as interdependent subsystems to facilitate matrix-guided cell migration, which is crucial for tissue formation and...
- This $1,417,500 Project Grant awarded by the National Institutes of Health (NIH) under the Trans-NIH Research Support program (CFDA 93.310) funds the development of "Electrified Cryo-EM", a novel tool that can kinetically trap biological systems in their metastable, non-equilibrium states. The research aims to unravel the structural changes in neurons during an action potential across multiple length scales, from voltage-gated channel proteins to the synaptic junction. Specifically,...
- Grant Award Summary Cornell University received a $375,154 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective June 1, 2026 through February 28, 2031. The award supports fundamental research to uncover the structure and function of understudied membrane proteins implicated in human diseases. Using Caenorhabditis elegans as a model organism, the research team will employ a...
- Grant Award Summary The National Eye Institute (NEI) awarded The Research Foundation for the State University of New York $896,500 under the Vision Research program (CFDA 93.867) to investigate the transcriptional dynamics of photoreceptor gene regulation. The project, which commenced September 1, 2025, and concludes August 31, 2027, develops advanced quantitative single-particle tracking photoactivated localization microscopy (SPTPALM) super-resolution imaging to characterize the nuclear...
- The National Science Foundation's (NSF) Chemistry of Life Processes Program awarded a Project Grant of $698,869 to the University of Michigan to develop new molecular tools to study brain signaling-specific neuronal populations. The goal is to create a new class of reporters that can quickly label neurons activated during specific behaviors, enabling further study of the neural circuits underlying cognitive functions and behaviors. This 5-year project will utilize directed evolution and rational...
- This $1,399,500 Project Grant award from the National Institutes of Health's Trans-NIH Research Support program (CFDA 93.310) will fund research at the University of Wisconsin - Madison to develop "cellular radio" circuits that can be used to visualize, probe, and perturb the dynamic protein activity in individual cells. The project aims to create genetically-engineered circuits that generate a frequency-modulated, barcoded fluorescent signal to track how the internal state of cells...
- The National Science Foundation (NSF) Division of Molecular and Cellular Biosciences awarded Emory University a $724,356 Project Grant under the Biological Sciences program (CFDA 47.074) to investigate the role of the protein ARL13B in controlling ciliary cyclic AMP (cAMP) signaling. The research aims to unravel the ciliary cAMP "signature", optogenetically stimulate cAMP signaling within normal and ARL13B-excluded cilia, investigate the role of ciliary cAMP signaling in remodeling...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded $423,734 to Rutgers, The State University of New Jersey, Camden Division on February 12, 2026, through its Biomedical Research and Research Training program (CFDA 93.859) to develop in vivo genetic and molecular platforms for investigating the co-evolution of cell-signaling proteins. Using Drosophila melanogaster as the model organism, the research will explore how Gurken (GRK), a TGF-alpha...
MOLECULAR MECHANISMS OF EPH RECEPTOR SIGNALING - PROJECT SUMMARY THE SURVIVAL OF EVERY MULTICELLULAR ORGANISM RELIES ON EFFECTIVE CELL-CELL COMMUNICATION. DESPITE THE DIVERSITY OF SIGNALS THAT CELLS NEED TO COMMUNICATE TO THEIR NEIGHBORS, EVOLUTION APPEARS TO HAVE SETTLED ON ONLY A FEW PHYSICAL MECHANISMS FOR TRANSFERRING INFORMATION ACROSS MEMBRANES. ONE SUCH MECHANISM IS THE OLIGOMERIZATION, OR CLUSTERING, OF MEMBRANE-SPANNING RECEPTOR PROTEINS, WHEREIN THE RECEIPT OF A SIGNAL ON ONE SIDE OF THE MEMBRANE IS CONVERTED INTO A BIOCHEMICAL RESPONSE ON THE OTHER SIDE. THE MECHANISMS AND REGULATION OF OLIGOMERIC TRANSITIONS REMAIN POORLY UNDERSTOOD FOR MOST FAMILIES OF RECEPTOR PROTEINS DUE TO THE INHERENT EXPERIMENTAL DIFFICULTY OF DETECTING AND PROBING THESE SUBTLE TRANSITIONS. MY LAB IS INTERESTED IN HARNESSING THE LATEST DEVELOPMENTS IN OPTOGENETICS, SINGLE-MOLECULE MICROSCOPY, GENOME EDITING, AND HIGH- THROUGHPUT SEQUENCING TO DISSECT THE RECEPTOR CLUSTERING EVENTS THAT ALLOW CELLS TO "TALK" TO EACH OTHER IN A SYSTEMATIC AND QUANTITATIVE WAY. THE PROPOSED RESEARCH PROGRAM WILL TACKLE THE ACTIVATION AND REGULATION OF EPH RECEPTORS IN HUMAN CELLS. EPH RECEPTORS CONSTITUTE THE LARGEST KNOWN FAMILY OF RECEPTOR TYROSINE KINASES (RTK'S) AND ARE LINKED TO A BROAD RANGE OF BIOLOGICAL PROCESSES IN BOTH HEALTH AND DISEASE, RANGING FROM TISSUE PATTERNING AND EMBRYONIC DEVELOPMENT TO NEURODEGENERATION AND CANCER. THE MECHANISTIC DETAILS BEHIND EPH RECEPTOR ACTIVATION REMAIN OBSCURE, IN LARGE PART BECAUSE OF THE LARGE NUMBER OF RECEPTOR TYPES THAT ARE OFTEN EXPRESSED IN A SINGLE CELL AND THEIR APPARENT ABILITY TO FROM BOTH HOMO- AND HETERO-OLIGOMERS OF VARYING STOICHIOMETRIES. OVER THE NEXT FIVE YEARS, WE WILL DEVELOP A COMBINED APPROACH FOR PRECISELY MANIPULATING AND DETECTING HOMO- AND HETERO-OLIGOMERIZATION OF EPH RECEPTORS, ALLOWING US TO DIRECTLY DETERMINE THE EFFECTS OF CLUSTER SIZE AND COMPOSITION ON THE DOWNSTREAM SIGNALING OUTCOMES. THIS APPROACH WILL ALSO ALLOW US TO REVEAL THE CRYPTIC ROLES OF HETERODIMERS BETWEEN EPH RECEPTORS OF DIFFERENT TYPES, INCLUDING THE TWO CATALYTICALLY INACTIVE MEMBERS OF THE FAMILY. LIGHT-INDUCIBLE OPTOGENETIC CLUSTERING IN LIVING CELLS WILL BE CROSS-VALIDATED WITH IN VITRO ENZYMOLOGY AND DIRECT OBSERVATION OF CLUSTERING IN SINGLE-MOLECULE TRACKING EXPERIMENTS, ENSURING THAT WE ARE FAITHFULLY RECAPITULATING THE BIOLOGICALLY RELEVANT OLIGOMERIC TRANSITIONS. IN ADDITION TO ITS IMMEDIATE SIGNIFICANCE TO THE EPH RECEPTOR FIELD, THE PROPOSED WORK WILL DEVELOP A BIOPHYSICAL FRAMEWORK FOR ANALYZING THE SIGNALING OF OTHER RECEPTOR FAMILIES AT THE CELL-CELL INTERFACE. FINALLY, THE SPATIALLY DEFINED AND NON-INVASIVE NATURE OF LIGHT MEANS THAT DEVELOPMENT OF OPTICALLY CONTROLLED RECEPTORS WILL SERVE AS A POWERFUL TOOL FOR THE STUDY OF CELL-CELL SIGNALING AT THE ORGANOID OR ORGANISMAL LEVEL.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $385.3k | 6/19/26 | ||
| Not listed | $385.3k | 6/17/25 | ||
| Not listed | $297.5k | 7/11/24 | ||
| Not listed | $297.5k | 7/11/24 |